Skip to main content

ScienceDex / Researcher record

Zhan, Chang-Guo

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #488
  • Rising Star
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Long-Funded

NIH Funding · FY2022

$6.4M
Full award amounts, FY2022
2
Records listing this PI
#488
By linked amount among FY2022 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$366,2501#16,565
2007$355,6291#19,490
2008$446,1863#15,506
2009$348,5161#24,079
2010$345,0311#24,890
2012$622,3501#12,528
2013$1,768,9513#3,141
2014$1,707,9292#3,538
2015$2,134,9933#2,562
2016$1,110,3011#6,078
2017$1,522,4791#3,955
2018$1,448,4271#4,579
2019$811,8351#10,634
2021$3,521,3421#1,285
2022$6,422,1112#488

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20061 record
  2. FY20071 record
  3. FY20083 records
  4. FY20091 record
  5. FY20101 record
  6. FY20121 record
  7. FY20133 records
  8. FY20142 records
  9. FY20153 records
  10. FY20161 record
  11. FY20171 record
  12. FY20181 record
  13. FY20191 record
  14. FY20211 record
  15. FY2022 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Zhan, Chang-Guo. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2022 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award categories

  • Pharmacology

FY2022 award records by amount

NIH award records listing Zhan, Chang-Guo as a PI. Multi-PI records show the full award amount for context.

  • 5U01DA051079-03U01Contact PI
    Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse
    University of Kentucky · Pharmacology (NIH department code)
    $4.7M
    award amount
  • 1R01DA056646-01R01Contact PI
    Ghrelin Deacylase as a Treatment for Opioid Polysubstance Abuse
    University of Kentucky · Pharmacology (NIH department code)
    $1.7M
    award amount

Award organization

Organizations that administered FY2022 awards listing Zhan, Chang-Guo as a PI.

FY2022 award administered by University of Kentucky (KY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    University of Kentucky
  2. 2007
    $500K Cumulative Funding
  3. 2008
    $1M Cumulative Funding
  4. 2012
    $2M Cumulative Funding
  5. 2012
    R01 Grant Holder
  6. 2013
    Entered Top 50% Nationally
    Ranked #3141
  7. 2013
    Entered Top 25% Nationally
    Ranked #3141
  8. 2014
    $5M Cumulative Funding
  9. 2014
    Program/Center Grant Leader
  10. 2017
    $10M Cumulative Funding
  11. 2021
    Entered Top 10% Nationally
    Ranked #1285
  12. 2022
    Entered Top 5% Nationally
    Ranked #488